Literature DB >> 23118272

Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units.

Yoshiro Hayashi1, Kenichiro Morisawa, Michael Klompas, Mark Jones, Hiran Bandeshe, Robert Boots, Jeffrey Lipman, David L Paterson.   

Abstract

BACKGROUND: Hospitals and quality improvement agencies are vigorously focusing on reducing rates of hospital-acquired infection. Ventilator-associated pneumonia (VAP) is notoriously difficult to diagnose and surveillance is thwarted by the subjectivity of many components of the surveillance definition. Alternative surveillance strategies are needed. Ventilator-associated complications (VAC) is a simple, objective measure of respiratory deterioration.
METHODS: VAC is defined by increases in fraction of inspired oxygen (FiO(2)) by ≥ 15% or positive end-expiratory pressure (PEEP) by ≥ 2.5 cm H(2)O lasting ≥ 2 days after stable or decreasing FiO(2) or PEEP lasting ≥ 2 days. We retrospectively assessed patients on mechanical ventilation for ≥ 48 hours in our study intensive care unit (ICU) using electronic medical record data. We analyzed the association between VAC and clinical diagnoses, ICU length of stay, duration of mechanical ventilation, antibiotic use, and mortality.
RESULTS: We assessed 153 patients with VAC and 390 without VAC. VAC events were associated with significantly increased ICU length of stay, duration of mechanical ventilation, and consumption of broad-spectrum antibiotics but not with longer hospital stays or ICU mortality.
CONCLUSIONS: Surveillance for VAP is subjective and labor intensive. VAC is an objective measure which can be readily obtained from electronic records. It is associated with adverse outcomes and increased broad-spectrum antibiotic usage. VAC may be a useful surveillance tool. The utility of VAC prevention bundles merits assessment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23118272     DOI: 10.1093/cid/cis926

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  38 in total

1.  Antibiotic prescription for respiratory tract infections in ventilated patients: where are we heading?

Authors:  Jordi Rello; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-06-28       Impact factor: 17.440

2.  The Severity of ICU-Acquired Pneumonia.

Authors:  Hugues Marechal; Nathalie Layios; Pierre Damas
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

3.  Reducing Hospital-Acquired Infections Among the Neurologically Critically Ill.

Authors:  John J Halperin; Stephen Moran; Doriann Prasek; Ann Richards; Charlene Ruggiero; Christina Maund
Journal:  Neurocrit Care       Date:  2016-10       Impact factor: 3.210

4.  Risk factors for ventilator-associated events: a case-control multivariable analysis.

Authors:  Sarah C Lewis; Lingling Li; Michael V Murphy; Michael Klompas
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

5.  Dual Carbon Dioxide Capture to Achieve Highly Efficient Ultra-Low Blood Flow Extracorporeal Carbon Dioxide Removal.

Authors:  Brian Y Chang; Steven P Keller
Journal:  Ann Biomed Eng       Date:  2020-02-18       Impact factor: 3.934

6.  Bundle of care decreased ventilator-associated events-implications for ventilator-associated pneumonia prevention.

Authors:  Mathilde Neuville; Bruno Mourvillier; Lila Bouadma; Jean-François Timsit
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

7.  Two-State Collaborative Study of a Multifaceted Intervention to Decrease Ventilator-Associated Events.

Authors:  Nishi Rawat; Ting Yang; Kisha J Ali; Mary Catanzaro; Mariah D Cohen; Donna O Farley; Lisa H Lubomski; David A Thompson; Bradford D Winters; Sara E Cosgrove; Michael Klompas; Kathleen A Speck; Sean M Berenholtz
Journal:  Crit Care Med       Date:  2017-07       Impact factor: 7.598

8.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

9.  Application of the New Centers for Disease Control and Prevention Surveillance Criteria for Ventilator-Associated Events to a Cohort of PICU Patients Identifies Different Patients Compared With the Previous Definition and Physician Diagnosis.

Authors:  Katherine M Ziegler; Jonathan D Haywood; Marci K Sontag; Peter M Mourani
Journal:  Crit Care Med       Date:  2019-07       Impact factor: 7.598

Review 10.  Improving ventilator-associated event surveillance in the National Healthcare Safety Network and addressing knowledge gaps: update and review.

Authors:  Shelley S Magill; Barry Rhodes; Michael Klompas
Journal:  Curr Opin Infect Dis       Date:  2014-08       Impact factor: 4.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.